Ammoxetine is a novel SNRI derived from duloxetine, exhibiting a 3- to 10-fold greater potency.
Jiayi (Bryan) Yan, BSPS, PharmD Candidate
Advertisement
Articles by Jiayi (Bryan) Yan, BSPS, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Outcomes of Older Patients on Enfortumab Vedotin for Urothelial Carcinoma
2
FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence
3
Are Non-Opioid Therapies Finally Challenging Opioids in Acute Pain Management?
4
Single-Center Experience With Vorasidenib in Patients With Grade 3 or 4 IDH-Mutant Gliomas
5